Cri­net­ics’ car­ci­noid syn­drome drug gears up for reg­is­tra­tional test af­ter PhII da­ta up­date

Cri­net­ics Phar­ma­ceu­ti­cals of­fered new in­sight in­to its drug pal­tuso­tine in ad­dress­ing car­ci­noid syn­drome symp­toms, set­ting plans in mo­tion fur­ther for a reg­is­tra­tional tri­al to start …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER